Re: Researchers Question If HPV Vaccine Is Worth the Risk
- From: Mike <Mike@xxxxxxx>
- Date: Thu, 28 Aug 2008 03:41:50 GMT
D. C. Sessions wrote:
In message <2cMsk.776$UX.543@trnddc03>, Mike wrote:
Does not count in my book for a long term track record.
Track records starts when the product reaches the market,
this is when real life testing begins.
But on the other hand, you've objected to marketing a
product without long-term testing.
I see a problem here ...
This is a distortion of my arguments that you conveniently removed.
The clinical trials are not a substitute for real life testing.
One reason is that they are limited and not much can be done
about that. This is why I would not advise anybody to use a new drug.
That does not mean I object to marketing such drugs.
I am opposed however to making them mandatory.
Would you mind if a beginner surgeon operates on your child?
Many people would. But it does not make them opponents of medical
schools. Same principle applies with drugs.
The problem is exacerbated by the fact that the trials are under
total control of the drug makers, and they cannot be trusted.
They naturally care only about their bottom line.
.
- References:
- Prev by Date: Re: Spider bite treatment
- Next by Date: rare form of lung cancer
- Previous by thread: Re: Researchers Question If HPV Vaccine Is Worth the Risk
- Next by thread: Re: Researchers Question If HPV Vaccine Is Worth the Risk
- Index(es):
Relevant Pages
|
